BioCryst Collaborates in Oncology with Mundipharma
By Business Review Editor
Pharma Deals Review: Vol 2006 Issue 69 (Table of Contents)
Published: 6 Mar-2006
DOI: 10.3833/pdr.v2006.i69.548 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Mundipharma International has entered into an exclusive in-licensing agreement for BCX-1777 (Fodosine™, forodesine hydrochloride) for oncology indications with BioCryst Pharmaceuticals...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS